// App-Quantinova.ai

POS1242 (2022) : BARICITINIB AND PULSE STEROIDS COMBINED TREATMENT IN SEVERE COVID-19 PNEUMONIA: PRELIMINARY DATA FROM A RHEUMATOLOGIC EXPERIENCE IN INTENSIVE CARE UNIT

Researchers

Presenter

  • F. Ferro

Principal Investigators

  • E. Elefante

  • N. Italiano

  • M. Moretti

  • G. La Rocca

  • R. Mozzo

  • L. De Simone

  • C. Baldini

  • M. Mosca

Medical Centers

  • Azienda Ospedaliero-Universitaria Pisana, Rheumatology Unit, Pisa, Italy

  • Rheumatology Unit, University of Pisa, Clinical and Experimental Medicine, Pisa, Italy

  • Azienda Ospedaliero-Universitaria Pisana, Anaesthesiology Unit, Pisa, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Severe COVID-19 pneumonia

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Methylprednisolone

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Baricitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved